Literature DB >> 309812

B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.

K H Robèrt, E Möller, G Gahrton, H Eriksson, B Nilsson.   

Abstract

The mitogenic response of blood lymphocytes from twelve patients with B-cell CLL and seven healthy controls was investigated. All patients were untreated and had a typical B-cell dominance in their peripheral blood. The patients demonstrated a scattered response pattern with a higher variance than in the control group. We demonstrated examples of stimulation of DNA-synthesis by polyclonal B-cell activators (PBA) as well as inhibition. The variable pattern between the patients might result from a malignant transformation of cells originating from different lymphocyte subpopulations in different patients. Thus PBA studies of lymphocytes from CLL patients might be a valuable tool in characterizing further this clinically variable disease at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309812      PMCID: PMC1537573     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Functional analysis of B cell heterogeneity.

Authors:  E Gronowicz; A Coutinho
Journal:  Transplant Rev       Date:  1975

2.  [Studies on the reactivity of T-lymphocytes in chronic lymphoid leukemia].

Authors:  J Hunyadi; A Dobozy; S Husz; A S Kenderessy; F Krizsa
Journal:  Z Hautkr       Date:  1976-05-01

3.  Further characterization of the circulating cell in chronic lymphocytic leukemia.

Authors:  E F Schultz; S Davis; A D Rubin
Journal:  Blood       Date:  1976-08       Impact factor: 22.113

4.  [Lymphocyte in chronic lymphatic leukemia].

Authors:  G Brittinger; W Augener; K Bremer; G Cohnen; S Dabag; K Fischer; E König; P Meusers
Journal:  Blut       Date:  1975-05

5.  Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD.

Authors:  P Ralph; I Nakoinz; W C Raschke
Journal:  Biochem Biophys Res Commun       Date:  1974-12-23       Impact factor: 3.575

6.  Evaluation of immunologic reactivity of lymphocytes from patients with chronic lymphocytic leukemia in various clinical conditions.

Authors:  Z Traczyk; S Cieśluk; J Litwin; E Arczyńska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1975       Impact factor: 4.291

7.  Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL).

Authors:  U Hellstrom; H Mellstedt; P Perlmann; G Holm; D PETTERSSON
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

8.  Macrophages are required for the dextran-sulfate induced activation of B lymphocytes.

Authors:  U C Persson; L L Hammarström; C I Smith
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

9.  Beta2-microglobulin on the cell surface. Specificity of inhibition of the mixed leukocyte reaction and mitogenic properties of antibodies against the two HLA antigen polypeptide chains.

Authors:  L Ostberg; J B Lindblom; P A Peterson
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

10.  Activation of human lymphocyte subpopulations by rabbit anti-human beta2-microglobulin and by lipopolysaccharide.

Authors:  O Ringdén
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

View more
  13 in total

1.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

2.  PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.

Authors:  K H Robert
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

3.  Functional and phenotypic heterogeneity of electrophoretically separated leukaemic B cells from patients with chronic lymphocytic leukaemia.

Authors:  C D Platsoucas
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

4.  J chain synthesis and ultrastructural changes in chronic lymphocytic leukaemia cells during in vitro differentiation.

Authors:  N Yasuda; H Shimada; T Kanoh; H Uchino
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia.

Authors:  J Cossman; L M Neckers; R M Braziel; J B Trepel; S J Korsmeyer; A Bakhshi
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.

Authors:  A P Johnstone; R E Millard; L Hudson
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

7.  Mitogen-induced maturation of chronic lymphocytic leukemia B lymphocytes.

Authors:  P Guglielmi; J L Preud'homme; R Ciorbaru-Barot; M Seligmann
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

8.  Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.

Authors:  A Danersund; T H Tötterman; K Nilsson; I Egle-Jansson; D Kabelitz; O Sjöberg
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  Interferon induces proliferation and differentiation in primary chronic lymphocytic leukaemia cells.

Authors:  K H Robert; S Einhorn; G Juliusson; L Ostlund; P Biberfeld
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

10.  Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.

Authors:  J Cossman; L M Neckers; S Hsu; D Longo; E S Jaffe
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.